Please login to the form below

Not currently logged in
Email:
Password:

Crucell

This page shows the latest Crucell news and features for those working in and with pharma, biotech and healthcare.

Janssen’s quest to prevent diseases taking hold

Janssen’s quest to prevent diseases taking hold

Janssen’s acquisition of Crucell in 2011 brought it a suite of promising platforms covering HIV, a universal flu vaccine, respiratory syncytial virus (RSV), which is an infection of the lungs

Latest news

  • Ebola vaccine halt 'a precaution' say researchers Ebola vaccine halt 'a precaution' say researchers

    Meanwhile, Johnson &Johnson (J&J) is also stepping up production of its own candidate - being developed by subsidiary Crucell in partnership with the Danish biotech Bavarian Nordic and the US National

  • J&J to produce one million doses of Ebola vaccine J&J to produce one million doses of Ebola vaccine

    The vaccine is being developed by J&J's Netherlands-based subsidiary Crucell in partnership with the Danish biotech Bavarian Nordic and the US National Institutes of Health (NIH). ... It combines Crucell's AdVac technology and Bavarian Nordi's MVA-BN

  • J&J fast-tracks Ebola vaccine J&J fast-tracks Ebola vaccine

    The US-based healthcare giant's subsidiary Crucell – based in the Netherlands – is collaborating with the Danish biotech Bavarian Nordic on a combination vaccine regimen with clinical trials in humans planned ... So far the regimen – which combines

  • Janssen boosts vaccines pipeline with GlycoVaxyn deal

    Its early development will see GlycoVaxyn collaborate with Janssen's vaccines- focused affiliate Crucell, but once the programme enters later-stage clinical studies, Janssen will take over development and then lead

  • J&J complete acquisition of Crucell

    As a result of the deal, Crucell will become the centre for vaccines within the J&J group. ... In October 2010, J&J reached an agreement with Crucell on its 24.75 a share purchase offer.

More from news
Approximately 1 fully matching, plus 20 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Origins Insights

Origins are part of the Resonant Group. Using novel research methodologies, we dig deeper to deliver authentic audience experiences that...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....